These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 8715799

  • 1. Settling the question: Sandimmune or Neoral?
    Hull AR.
    Nephrol News Issues; 1996 May; 10(5):9. PubMed ID: 8715799
    [No Abstract] [Full Text] [Related]

  • 2. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
    Roth D, Miller J.
    Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
    [No Abstract] [Full Text] [Related]

  • 3. An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients.
    Park K, Koh YB, Kwak JY, Kim SJ, Yoon YS, Kang CM, Kim YS.
    Transplant Proc; 1996 Jun; 28(3):1202-3. PubMed ID: 8658627
    [No Abstract] [Full Text] [Related]

  • 4. Neoral versus Sandimmune in kidney transplantation.
    Tisone G, Orlando G, Mercadante E, Vennarecci G, Pisani F, Buonomo O, Negrini S, Casciani CU.
    Transplant Proc; 1998 Aug; 30(5):1749-50. PubMed ID: 9723265
    [No Abstract] [Full Text] [Related]

  • 5. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
    Serafinowicz A, Gaciong Z, Baçzkowska T, Rell K, Lao M, Wałaszewski J.
    Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine.
    Bökenkamp A, Offner G, Hoyer PF, Wonigeit K, Brodehl J.
    Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223
    [No Abstract] [Full Text] [Related]

  • 8. Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.
    Chapman JR, O'Connell PJ, Bovington KJ, Allen RD.
    Transplant Proc; 1996 Aug; 28(4):2293-5. PubMed ID: 8769229
    [No Abstract] [Full Text] [Related]

  • 9. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
    Griffin PJ, Moore RH, Jurewicz WA, Lord RH, Webley Y, Jenkins J.
    Transplant Proc; 1997 Aug; 29(1-2):303. PubMed ID: 9123007
    [No Abstract] [Full Text] [Related]

  • 10. Cyclosporine neoral monitoring and its correlation with the "area under the curve".
    Sabbatiello R, Sgrosso JL, Schiavelli R, Castro C, Ahualli L, Pattin M, Vazquez MC.
    Transplant Proc; 1996 Dec; 28(6):3378. PubMed ID: 8962317
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C, Laine J, Jalanko H, Leijala M, Hoppu K.
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract] [Full Text] [Related]

  • 15. Neoral C2 monitoring in solid organ transplantation.
    Levy GA.
    Transplant Proc; 2004 Mar; 36(2 Suppl):392S-395S. PubMed ID: 15041373
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Case reports on conversion to Neoral therapy in renal transplant patients.
    Curtis JJ.
    Transplant Proc; 1996 Aug; 28(4):2221-2; discussion 2218. PubMed ID: 8769205
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.